Immunotherapy: Viral reprogramming

Nature Reviews Cancer 18, 135 (2018).
doi:10.1038/nrc.2018.12

Author: Anna Dart
Two studies have shown that oncolytic virus treatment prior to surgery can prime the tumour immune microenvironment for subsequent immune checkpoint inhibition and lead to better outcomes in preclinical models of breast and brain cancers.

Source: Nature Reviews Cancer - February 9, 2018 Category: Cancer & Oncology Authors: Anna Dart Tags: Research Highlight Source Type: research